Cargando…

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation

OBJECTIVES: Prucalopride is effective at alleviating symptoms of chronic constipation in women. The aim of this study was to assess the efficacy of 12 weeks of prucalopride treatment compared with placebo in men with chronic constipation. METHODS: This was a multicenter, stratified, randomized, para...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yiannakou, Yan, Piessevaux, Hubert, Bouchoucha, Michel, Schiefke, Ingolf, Filip, Rafal, Gabalec, Libor, Dina, Ion, Stephenson, David, Kerstens, René, Etherson, Kevin, Levine, Amy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Functional GI Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424376/ https://www.ncbi.nlm.nih.gov/pubmed/25869393 http://dx.doi.org/10.1038/ajg.2015.115

Ejemplares similares

Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis
por: Emmanuel, Anton, et al.
Publicado: (2014)

A Randomized, Placebo-Controlled Trial of Lubiprostone for Opioid-Induced Constipation in Chronic Noncancer Pain
por: Jamal, M Mazen, et al.
Publicado: (2015)

A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation
por: Chey, William D, et al.
Publicado: (2011)

Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial
por: Chey, William D, et al.
Publicado: (2017)

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Schoenfeld, Philip, et al.
Publicado: (2018)

The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing Symptoms, Care Seeking, and Disease Burden
por: Heidelbaugh, Joel J, et al.
Publicado: (2015)

A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation
por: Miner Jr, Philip B, et al.
Publicado: (2017)

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
por: Rao, Satish, et al.
Publicado: (2012)

Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials
por: Camilleri, Michael, et al.
Publicado: (2016)

Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea
por: Pattni, Sanjeev S, et al.
Publicado: (2012)

Qualitative Development of a Patient-Reported Outcome Symptom Measure in Diarrhea-Predominant Irritable Bowel Syndrome
por: Marquis, P, et al.
Publicado: (2014)

The Epidemiology of Irritable Bowel Syndrome in the US Military: Findings from the Millennium Cohort Study
por: Riddle, Mark S, et al.
Publicado: (2016)

Association Between the Location of Diverticular Disease and the Irritable Bowel Syndrome: A Multicenter Study in Japan
por: Yamada, Eiji, et al.
Publicado: (2014)

The Effect of High-Fat Diet-Induced Pathophysiological Changes in the Gut on Obesity: What Should be the Ideal Treatment?
por: Y Lee, Chooi
Publicado: (2013)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Distinct Abnormalities of Small Bowel and Regional Colonic Volumes in Subtypes of Irritable Bowel Syndrome Revealed by MRI
por: Lam, Ching, et al.
Publicado: (2017)

Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus
por: Rezaie, Ali, et al.
Publicado: (2017)

Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome
por: Sayuk, Gregory S, et al.
Publicado: (2017)

Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use
por: Lacy, Brian E, et al.
Publicado: (2017)

Effect of prucalopride on symptoms of chronic constipation
por: Tack, J, et al.
Publicado: (2013)

Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation
por: Dik, Vincent K., et al.
Publicado: (2014)

Efficacy of Prucalopride for Chronic Idiopathic Constipation: An Analysis of Participants With Moderate to Very Severe Abdominal Bloating
por: Staller, Kyle, et al.
Publicado: (2022)

Efficacy and Safety of Prucalopride in Patients with Chronic Noncancer Pain Suffering from Opioid-Induced Constipation
por: Sloots, Cornelius E. J., et al.
Publicado: (2010)

Development of a population pharmacokinetic model of prucalopride in children with functional constipation
por: van Schaick, Erno, et al.
Publicado: (2016)

Functional bowel symptoms, fibromyalgia and fatigue: A food-induced triad?
por: Berstad, Arnold, et al.
Publicado: (2012)

Diagnostic pitfalls in functional neurological disorders
por: Pimentel, Lucio Huebra, et al.
Publicado: (2022)

The PAC‐SYM questionnaire for chronic constipation: defining the minimal important difference
por: Yiannakou, Y., et al.
Publicado: (2017)

Prucalopride: the evidence for its use in the treatment of chronic constipation
por: Coremans, Georges
Publicado: (2008)

Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands
por: Nuijten, Mark J. C., et al.
Publicado: (2015)

Patient considerations in the management of chronic constipation: focus on prucalopride
por: Shin, Andrea
Publicado: (2016)

Clinical Efficacy and Safety Profile of Prucalopride in Chronic Idiopathic Constipation
por: Tameez Ud Din, Asim, et al.
Publicado: (2019)

Transanal Irrigation for Refractory Chronic Idiopathic Constipation: Patients Perceive a Safe and Effective Therapy
por: Etherson, Kevin J., et al.
Publicado: (2017)

Role of Prucalopride in Treating Functional Constipation and Gastroparesis: A Systemic Review
por: Ali, Hassam, et al.
Publicado: (2021)

A Review of the Cardiovascular Safety of Prucalopride in Patients With Chronic Idiopathic Constipation
por: Tack, Jan, et al.
Publicado: (2023)

Response to letter: Balancing risks and benefits of prucalopride for the treatment of chronic constipation in Asians
por: Ke, M, et al.
Publicado: (2013)

Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study
por: Ke, M, et al.
Publicado: (2012)

Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study
por: Mendzelevski, Boaz, et al.
Publicado: (2012)

Prucalopride: A Recently Approved Drug by the Food and Drug Administration for Chronic Idiopathic Constipation
por: Mahajan, Rajiv
Publicado: (2019)

Effect of Prucalopride in the Treatment of Chronic Constipation in Asian and Non-Asian Women: A Pooled Analysis of 4 Randomized, Placebo-controlled Studies
por: Ke, MeiYun, et al.
Publicado: (2014)

Gastric microbiota in the functional dyspepsia patients treated with probiotic yogurt
por: Nakae, Hirohiko, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h6onpr8c4iigc4ge06ue5784hk